Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTRevolutionize parvovirus care in your clinicPuppies treated with our Canine Parvovirus Monoclonal Antibody recovered faster: heading home from the clinic nearly two days earlier.1 Join 9 out of 10 satisfied veterinarians. + Read More